A major advance in cancer investigation is arising with the use of nanobodies to re-engage mutated p53. This crucial cancer suppressor protein is frequently inactivated in several forms of cancer, resulting https://getsocialselling.com/story7487360/mini-antibodies-revive-tumor-suppressor-p53-the-new-pathway-for-malignant-therapy